Private Ocean’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Private Ocean’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$229K	–	402
2018 Q1	$229K	Hold	10,000	–	–	0.11%	74
2017 Q4	$259K	Buy	+10,000	New	+$201K	0.14%	44

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Private Ocean's CNCE Position: Q2 2018 in Review

Private Ocean sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2018, closing a stake of 10,000 shares — an estimated $229K sold.

Private Ocean first reported a position in CNCE in Q4 2017 and held it in 2 quarters. The position peaked at $259K in Q4 2017. 120 funds tracked by Wall St. Rank hold CNCE as of Q2 2018.

Private Ocean reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Private Ocean sold 10,000 Concert Pharmaceuticals, Inc. shares in Q2 2018, an estimated $229K.
Private Ocean first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
Private Ocean's Concert Pharmaceuticals, Inc. position peaked at $259K in Q4 2017.
120 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2018.

Based on Private Ocean's 13F filing for Q2 2018, filed 9 Aug 2018.